Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Declines By 84.1%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 2,200 shares, a drop of 84.1% from the February 28th total of 13,800 shares. Based on an average daily trading volume, of 29,700 shares, the short-interest ratio is presently 0.1 days.

Cardio Diagnostics Price Performance

Cardio Diagnostics stock traded down $0.01 during trading hours on Wednesday, hitting $0.03. The company had a trading volume of 12,300 shares, compared to its average volume of 23,264. The company has a 50-day moving average price of $0.06 and a two-hundred day moving average price of $0.05. Cardio Diagnostics has a 1 year low of $0.02 and a 1 year high of $0.18.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.